Aurinia Pharm Ord
(AUPH)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -26,206 | -108,180 | -82,134 | -73,145 | -37,630 |
| Depreciation Amortization | 717 | 2,706 | 2,487 | 1,374 | 978 |
| Accounts receivable | -5,559 | 1,927 | -26,356 | -2,758 | -4,986 |
| Other Working Capital | -13,254 | -6,817 | -38,781 | -22,739 | -18,491 |
| Other Operating Activity | 12,632 | 30,835 | 54,805 | 22,651 | 13,383 |
| Operating Cash Flow | $-31,670 | $-79,529 | $-89,979 | $-74,617 | $-46,746 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | 464,316 | -57,075 | N/A | N/A |
| PPE Investments | -509 | -292 | -158 | -118 | -79 |
| Purchase Of Investment | -142,397 | -523,993 | N/A | -232,955 | -163,504 |
| Sale Of Investment | 167,766 | N/A | N/A | 225,677 | 110,566 |
| Other Investing Activity | 0 | -663 | -381 | 0 | 0 |
| Investing Cash Flow | $24,860 | $-60,632 | $-57,614 | $-7,396 | $-53,017 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 1,639 | 2,433 | 1,745 | 1,745 | 405 |
| Financing Cash Flow | $1,639 | $2,433 | $1,745 | $1,745 | $405 |
| Beginning Cash Position | 94,172 | 231,900 | 231,900 | 231,900 | 231,900 |
| End Cash Position | 89,001 | 94,172 | 86,052 | 151,632 | 132,542 |
| Net Cash Flow | $-5,171 | $-137,728 | $-145,848 | $-80,268 | $-99,358 |
| Free Cash Flow | |||||
| Operating Cash Flow | -31,670 | -79,529 | -89,979 | -74,617 | -46,746 |
| Capital Expenditure | -509 | -292 | -158 | -118 | -79 |
| Free Cash Flow | -32,179 | -79,821 | -90,137 | -74,735 | -46,825 |